Pharmacological alteration of antigen-induced contraction of lung parenchymal strips isolated from the actively sensitized guinea pig

European Journal of Pharmacology
V SongsiridejC K Buckner

Abstract

Several drugs, known to influence the action or formation of histamine and SRS-A, were examined for their abilities to alter antigen (ovalbumin)-induced contractions of guinea-pig isolated lung parenchymal strips. Cumulative dose-response effects of ovalbumin were obtained on paired parenchymal strips, one used as control and the other drug treated. When used alone, mepyramine, 10(-6) M, phenoxybenzamine, 3 x 10(-5) M and FPL55712, 10(-5) M, did not alter ovalbumin-induced contractions, 5,8,11,14-eicosatetraynoic acid (ETYA), 10(-4) M, produced a small (2.5-fold) rightward shift of the dose-response curves to ovalbumin and histamine. Indomethacin, 5 x 10(-6) M, produced a small increase in the maximum response to ovalbumin and a small (2-fold) rightward shift of the histamine dose-response curve. The effect of indomethacin on ovalbumin-induced contraction was not seen in the presence of phenoxybenzamine and may therefore be due to an increase in histamine release. Combination of indomethacin with FPL55712 or ETYA did not alter antigen-induced contractions. The effect of ETYA on the histamine dose-response curve was not seen in the presence of indomethacin. Combination of phenoxybenzamine with FPL55712 or ETYA caused a marked re...Continue Reading

References

Feb 15, 1979·European Journal of Pharmacology·H W Mitchell, M A Denborough
Aug 28, 1979·Biochemical and Biophysical Research Communications·N A PorterH Weenen
Oct 1, 1979·The Journal of Experimental Medicine·D A KennerlyC W Parker
Oct 1, 1979·Agents and Actions·K Forsberg, L Sörenby
Feb 1, 1976·European Journal of Pharmacology·V A Alabaster, Y S Bakhle
Oct 17, 1973·Nature: New Biology·J AugsteinM L Tattersall
Sep 8, 1970·Biochimica Et Biophysica Acta·D G Ahern, D T Downing
Apr 9, 1981·European Journal of Pharmacology·J F Burka, N A Paterson
Jul 1, 1980·Allergy·B SamuelssonP Borgeat
Dec 17, 1981·European Journal of Pharmacology·J M HandC K Buckner
Jul 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·J M DrazenE J Corey
Feb 1, 1981·Journal of Medicinal Chemistry·P Borgeat, P Sirois
Sep 1, 1981·Biochemical Pharmacology·G FolcoE Graström

❮ Previous
Next ❯

Citations

Jun 8, 1989·European Journal of Pharmacology·D G Redkar-Brown, D Aharony
Nov 1, 1987·British Journal of Pharmacology·J RandonB B Vargaftig
Apr 1, 1985·British Journal of Pharmacology·A DetsouliB B Vargaftig
May 26, 2009·American Journal of Physiology. Lung Cellular and Molecular Physiology·Liliana Moreno-VinascoDavid B Jacoby
Sep 1, 1985·Annales De L'Institut Pasteur. Immunology·B B Vargaftig

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atopic Dermatitis

Atopic dermatitis is a chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. Discover the latest research on atopic dermatitis here.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.